Abstract
Today mistletoe extracts play an important role in adjuvant cancer treatment because of their immunostimulating properties. Clinical studies have shown that mistletoe lectin I enhances the secretion of cytokines and interleukins and increases the number of natural killer cells. As recognition and binding of mistletoe lectins to sugar chains present on the cell surface of immunogenic cells is the first step in biological activity, knowledge on sugar binding properties of lectins is significant in determining their medicinal potential. In order to enhance knowledge on possible binding sites of mistletoe lectins, we examined interaction of ML I with an arabinogalactan-protein (AGP) from Echinacea purpurea.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
